Literature DB >> 24915819

[Guidelines for HER2 detection in breast cancer, the 2014 version].

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24915819

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


× No keyword cloud information.
  5 in total

1.  Clinicopathological study of centrally necrotizing carcinoma of the breast.

Authors:  Yanling Zhang; Yurong Ou; Donghong Yu; Xiang Yong; Xiaoli Wang; Bo Zhu; Qiong Zhang; Lei Zhou; Zhaogen Cai; Zenong Cheng
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

2.  MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.

Authors:  XiaoRong Zhong; GuiQin Xie; Zhang Zhang; Zhu Wang; Yu Wang; YanPing Wang; Yan Qiu; Li Li; Hong Bu; JiaYuan Li; Hong Zheng
Journal:  Oncotarget       Date:  2016-09-20

3.  Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.

Authors:  Xu Liu; Dan Zheng; Yanqi Wu; Chuanxu Luo; Yu Fan; Xiaorong Zhong; Hong Zheng
Journal:  BMC Cancer       Date:  2021-03-05       Impact factor: 4.430

4.  The role of BRCA status on prognosis in patients with triple-negative breast cancer.

Authors:  Yuxin Xie; Qiheng Gou; Qianqian Wang; Xiaorong Zhong; Hong Zheng
Journal:  Oncotarget       Date:  2017-08-03

5.  Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients.

Authors:  Ling Deng; Xuehua Zhu; Yun Sun; Jiemin Wang; Xiaorong Zhong; Jiayuan Li; Min Hu; Hong Zheng
Journal:  Cancer Res Treat       Date:  2018-03-15       Impact factor: 4.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.